Mylan CEO defends EpiPen price hike in congressional hearing
The fight over the price of the EpiPen, an emergency treatment device for severe allergic reactions, has officially reached Capitol Hill. CEO Heather Bresch of Mylan, the company that makes the EpiPen, defended the drug's drastic price increase during a congressional hearing Wednesday as a balance between "price and access," pointing out that Mylan only profits $50 for each two-pack sold and that it has in the past distributed EpiPens to schools for free.
"Looking back, I wish we had better anticipated the magnitude and acceleration of the rising financial issues for a growing minority of patients, who may have ended up paying the [list price] or more. We never intended this," Bresch said in a statement released ahead of the hearing.
Rep. Elijah Cummings (D-Md.) accused Mylan of raising the price of a potentially lifesaving drug — despite keeping its ingredients virtually unchanged — when it acquired EpiPen in 2007, in order "to get filthy rich at the expense of our constituents." Cummings also compared Mylan's tactics to those of Martin Shkreli, the widely-loathed pharmaceutical executive who raised the price of a lifesaving cancer and HIV drug by 5,000 percent.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Since Mylan acquired EpiPen, the price of the device has risen more than 500 percent, to $608 for a two-pack.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
'Without mandatory testing, bird flu will continue circulating at farms across the country'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Thirteen missing after Red Sea tourist boat sinks
Speed Read The vessel sank near the Egyptian coastal town of Marsa Alam
By Arion McNicoll, The Week UK Published
-
Khan supporters converge on Islamabad
Speed Read Protesters clashing with Pakistani authorities are demanding the release of jailed former prime minister Imran Khan
By Rafi Schwartz, The Week US Published
-
US charges Indian tycoon with bribery, fraud
Speed Read Indian billionaire Gautam Adani has been indicted by US prosecutors for his role in a $265 million scheme to secure solar energy deals
By Peter Weber, The Week US Published
-
Boeing machinists approve contract, end strike
Speed Read The company's largest union approved the new contract offer, ending a seven-week strike
By Peter Weber, The Week US Published
-
US economy still strong in final preelection report
Speed Read It grew at a solid 2.8% annual rate from July through September
By Peter Weber, The Week US Published
-
Boeing machinists reject deal, continue strike
Speed Read The rejection came the same day Boeing reported a $6.2 billion quarterly loss
By Peter Weber, The Week US Published
-
Ports reopen after dockworkers halt strike
Speed Read The 36 ports that closed this week, from Maine to Texas, will start reopening today
By Peter Weber, The Week US Published
-
Empty-nest boomers aren't selling their big homes
Speed Read Most Americans 60 and older do not intend to move, according to a recent survey
By Peter Weber, The Week US Published
-
Brazil accuses Musk of 'disinformation campaign'
Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
By Rafi Schwartz, The Week US Published
-
Disney board fends off Peltz infiltration bid
Speed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
By Rafi Schwartz, The Week US Published